We are exploring new ways to think about and treat central nervous system (CNS) disorders.
Advancing a Leading Brain Health Portfolio
Our differentiated approach to drug discovery and development has allowed us to create a broad portfolio of fully-owned product candidates with the potential for development in a wide range of psychiatric, neurological and related central nervous system (CNS) disorders.
Please refer to the U.S. Prescribing Information for brexanolone.
Safety and efficacy for investigational uses or compounds have not been established. There is no guarantee that the outcome of these studies will result in approval by a Health Authority.